Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03555721 · ClinicalTrials.gov registry record
CytID Analysis of Oral Lesions
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- 18
- Enrollment target
NCT03555721: Clinical Trial study, sponsored by The University of Texas Health Science Center, Houston.
NCT03555721 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03555721 was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to correlate the results from a standard of care biopsy with CytID™ and hpvID™ swab tests for potentially premalignant and malignant oral lesions. The biopsy is considered standard of care and will be performed regardless of the patient's enrollment in the study. The study-related data gathering will not influence the treatment decisions of the clinician.
Interventions
- OTHER Oral examination with incandescent light
- OTHER Oral examination with OralID
- DIAGNOSTIC_TEST Biopsy
- DIAGNOSTIC_TEST CytID
- DIAGNOSTIC_TEST hpvID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-05-30 |
| Est. Completion | 2022-11-01 |
Why NCT03555721 stopped before completion
NCT03555721 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Oral examination with incandescent light is the first listed.
NCT03555721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03555721 about?
NCT03555721 is a clinical study titled "CytID Analysis of Oral Lesions". The purpose of this study is to correlate the results from a standard of care biopsy with CytID™ and hpvID™ swab tests for potentially premalignant and malignant oral lesions. The biopsy is considered standard of care and will be performed regardless of the patient's enrollment in the study. The stu...
What is the current status of trial NCT03555721?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2018-05-30. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03555721?
The interventions under investigation include: Oral examination with incandescent light (OTHER), Oral examination with OralID (OTHER), Biopsy (DIAGNOSTIC_TEST), CytID (DIAGNOSTIC_TEST), hpvID (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03555721?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI